Sat, Dec 27, 2014, 8:21 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Avid Technology, Inc. Message Board

  • wcoastguy2008 wcoastguy2008 Oct 22, 2012 2:22 PM Flag

    Mannkind - MNKD - Consider Buying A Few Shares Under $2.00

    The announcement that Mannkind has issued a new secondary to raise funds has created a buying opportunity.

    Mannkind's insulin drug, Afrezza, could receive F.D.A. approval as early as September,2013 if it is granted "priority review" status.

    With $1.6 billion in tax-loss carry forwards and insulin inventory to produce $10,000,000,000 worth of Afrezza the company in a potential takeover target which may be why Mr. Mann probably decided to convert so much debt to equity at $2.59/share last week.

    A "big-pharma" partnership could happen at any time.

    Consider buying a few shares below $2.00 before the approval run-up begins.

 
AVID
14.38+0.02(+0.14%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Prothena Corporation plc
NASDAQFri, Dec 26, 2014 4:00 PM EST
TherapeuticsMD, Inc.
AMEXFri, Dec 26, 2014 4:01 PM EST